Mushroom poisoning

Area of Science:

• Toxicology
• Infectious Diseases
• Gastroenterology

Background:

• Mycetismus, or mushroom poisoning, presents a significant public health concern.
• Delayed diagnosis and treatment are associated with poorer outcomes.
• Understanding the clinical manifestations and laboratory findings is crucial for effective management.

Purpose of the Study:

• To analyze the clinical characteristics and outcomes of patients diagnosed with mycetismus.
• To identify risk factors and predictors of severe poisoning.
• To differentiate between true mushroom toxin poisoning and other causes of gastrointestinal distress.

Main Methods:

• Retrospective analysis of 207 patients treated for mycetismus between 1983 and 1992.
• Categorization of patients based on latent time (time from ingestion to symptom onset).
• Evaluation of clinical symptoms, laboratory parameters (PT, GGT, AST, ALT, urea), and mortality rates.

Main Results:

• 75% of patients had a latent time < 6 hours, while 25% had > 6 hours.
• Severe liver and kidney damage, likely from Amanita phalloides, was observed in 11 patients with latent times of 9-13 hours, resulting in 3 fatalities.
• 40 patients with latent time > 6 hours experienced gastrointestinal symptoms without pathological lab findings and had no mortalities.

Conclusions:

• Delayed onset of mycetismus symptoms (> 6 hours) is associated with a higher risk of severe poisoning and potential fatalities.
• Early gastrointestinal symptoms without significant laboratory abnormalities may indicate less severe mushroom toxin exposure.
• Prompt medical attention and understanding of symptom latency are critical in managing mushroom poisoning.